The fear of COVID-19, which once reshaped the way Hawaii residents regarded seasonal gatherings, seems now a thing of the past. But the potential for that or another virus to morph into a threat h ...
Select an option below to continue reading this premium story. Already a Honolulu Star-Advertiser subscriber? Log in now to continue reading. That virus has not yet shown the capacity for human-to ...
Cystic fibrosis is a life-threatening genetic disorder that causes sticky mucus to build up in the lungs and digestive system. Credit: Iren_Geo via Shutterstock. Vertex Pharmaceuticals has secured two ...
We've tested a lot of different language learning apps, from Duolingo to Rosetta Stone. These are our top picks. Shelby Brown (she/her/hers) is an editor for CNET's services team. She covers tips ...
Vertex Pharmaceuticals said the Food and Drug Administration approved a new treatment for cystic fibrosis. The treatment, called alyftrek, is designed to treat cystic fibrosis in patients six ...
Vertex Pharmaceuticals said Friday the U.S. Food and Drug Administration expanded its approval of a cystic fibrosis treatment, encompassing more patients with different types of mutations of the ...
The drugmaker, with almost $10 billion in sales last year, has significantly impacted cystic fibrosis treatment, turning it from a disease with a median death age of around 30 years to a ...
“I had time, something of value that I could give to the process of understanding the disease and finding good treatments,” he says. In 2024, he was accepted into a radical trial. That ...
"In Phase 3 clinical trials, across a broad range of genotypes, once-daily ALYFTREK demonstrated non-inferiority to TRIKAFTA in ppFEV 1 response and statistically significant improvement in SwCl, a ...